EXPLORATION OF THE PROGNOSTIC AND IMMUNOTHERAPEUTIC VALUE OF B AND T LYMPHOCYTE ATTENUATOR IN SKIN CUTANEOUS MELANOMA

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma

B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to Golf the CD28 immunoglobulin superfamily.However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been widely characterized.We found that BTLA levels were upregulated in metastatic melanoma compared to normal skin

read more



The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study

Background A prescribing monitoring policy (PMP) was implemented in November 2015 in Anhui province, China, the first province to pilot this policy to manage the use and costs of select drugs based on their large prescription volumes and/or costs in hospitals.This study evaluated the impact of PMP on the use and expenditures of different drugs in t

read more